Mark J Sierestad

Title: Mark J Sierestad: Innovator in Pharmaceutical Chemistry

Introduction

Mark J Sierestad is a notable inventor based in San Diego, CA. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target fatty acid amide hydrolase (FAAH) activity. His work has implications for treating various medical conditions, including anxiety and diabetes.

Latest Patents

Mark J Sierestad holds a patent for "Heteroaryl-substituted urea modulators of fatty acid amide hydrolase." This patent describes certain heteroaryl-substituted piperidinyl and piperazinyl urea compounds that serve as FAAH inhibitors. These compounds are valuable in pharmaceutical compositions and methods for treating diseases and disorders mediated by FAAH activity, such as pain, inflammation, and sleep disorders.

Career Highlights

Mark J Sierestad is associated with Janssen Pharmaceutica NV, where he applies his expertise in pharmaceutical research and development. His innovative work has contributed to advancements in therapeutic options for various health conditions.

Collaborations

Throughout his career, Mark has collaborated with esteemed colleagues, including J Guy Breitenbucher and John M Keith. These partnerships have fostered a collaborative environment that enhances the development of effective pharmaceutical solutions.

Conclusion

Mark J Sierestad's contributions to pharmaceutical chemistry and his innovative patent work exemplify the impact of dedicated inventors in the medical field. His research continues to pave the way for new treatments that address critical health issues.